Calidi Biotherapeutics appointed Corsee Sanders as an independent director to its Board of Directors, effective June 17, 2026. The announcement is a routine governance update with limited immediate financial impact. No operational, earnings, or capital structure changes were disclosed.
Calidi Biotherapeutics appointed Corsee Sanders as an independent director to its Board of Directors, effective June 17, 2026. The announcement is a routine governance update with limited immediate financial impact. No operational, earnings, or capital structure changes were disclosed.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
